Resistance to Dopamine Agonists in Pituitary Tumors: Molecular Mechanisms.

Pivonello C, Patalano R, Negri M, Pirchio R, Colao A, Pivonello R, Auriemma RS

DOI: 10.3389/fendo.2021.791633
Published: 2021
Container: Frontiers in endocrinology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fendo.2021.791633,
  title = {Resistance to Dopamine Agonists in Pituitary Tumors: Molecular Mechanisms.},
  author = {Pivonello C and Patalano R and Negri M and Pirchio R and Colao A and Pivonello R and Auriemma RS},
  year = {2021},
  journal = {Frontiers in endocrinology},
  doi = {10.3389/fendo.2021.791633},
  url = {https://doi.org/10.3389/fendo.2021.791633}
}

RIS

TY  - JOUR
TI  - Resistance to Dopamine Agonists in Pituitary Tumors: Molecular Mechanisms.
AU  - Pivonello C
AU  - Patalano R
AU  - Negri M
AU  - Pirchio R
AU  - Colao A
AU  - Pivonello R
AU  - Auriemma RS
PY  - 2021
JO  - Frontiers in endocrinology
DO  - 10.3389/fendo.2021.791633
UR  - https://doi.org/10.3389/fendo.2021.791633
ER  -

APA

C, P., R, P., M, N., R, P., A, C., R, P., & RS, A. (2021). Resistance to Dopamine Agonists in Pituitary Tumors: Molecular Mechanisms.. Frontiers in endocrinology. https://doi.org/10.3389/fendo.2021.791633

Source records

pubmed · retrieved 2026-09-25T08:54:01.543Z